MicroRNA in pancreatic cancer: Pathological, diagnostic and therapeutic implications

78Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.
Get full text

Abstract

MicroRNAs (miRNAs) are a group of small non-coding RNA molecules of 17-25 nucleotides (nt) in length, predicted to control the activity of about 30% of all protein-coding genes in mammals. Altered expressions of miRNAs are reported in various cancers and may associate with cancer pathogenesis, apoptosis, and cell growth, thereby functioning as either tumor suppressors or oncogenes. Recent reports showed that deregulation of miRNA contribute to tumor development and progression and hence, have diagnostic and prognostic value in several human malignancies. This review discusses the current status of miRNA in pancreatic cancer development, progression, diagnosis, and therapy. © 2009 Elsevier Ireland Ltd.

Cite

CITATION STYLE

APA

Rachagani, S., Kumar, S., & Batra, S. K. (2010, June). MicroRNA in pancreatic cancer: Pathological, diagnostic and therapeutic implications. Cancer Letters. https://doi.org/10.1016/j.canlet.2009.11.010

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free